Trials / Completed
CompletedNCT01077180
Rheos Feasibility Trial
Rheos Feasibility Trial- A Study of Baroreflex Hypertension TherapyTM in Refractory Hypertension
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- CVRx, Inc. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The Rheos Feasibility Trial is designed to assess safety, device performance, and protocol parameters of the CVRx Rheos Baroreflex Therapy in patients with severe hypertension that are refractory to full drug therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Implantation of the Rheos System | Open label |
| OTHER | Standard of care medical management | Patients will continue with medical therapy for standard of care of their hypertension. |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2007-12-01
- Completion
- 2010-10-01
- First posted
- 2010-02-26
- Last updated
- 2019-07-02
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT01077180. Inclusion in this directory is not an endorsement.